The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.A cine was received and reviewed by an abbott vascular clinical specialist who provided the following summary: this incident concerns an rx acculink carotid stent (7-10x40mm) implanted (b)(6) 2021.The provided media (photos) shows the acculink stent successfully implanted with the distal half of the stent clearly covering the lesion while the proximal half of the stent is in healthy tissue.From the provided photos it cannot be determined how well opposed the proximal half of the stent is within the artery, contrast injection would be needed.On 07 june 2022 it was discovered that the acculink stent in question had migrated proximally to the point where most of the stent is no longer within the lesion.The provided photos confirm this proximal migration and that only a couple millimeters of the distal stent are located at the site of the lesion, providing no clinical benefit.It is difficult to determine a probable cause of the stent migration without more clinical information, specifically contrast injections displaying the anatomy of the entire artery.It is possible that anatomical conditions and/or repetitive movement over time contributed to the reported stent migration; however this cannot be confirmed.The investigation determined a conclusive cause for the reported migration cannot be determined.The treatment appears to be related to the operational context of the procedure as reportedly a non-abbott stent was used to overlap and treat the lesion.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|